跳至主要内容
临床试验/CTRI/2018/01/011204
CTRI/2018/01/011204尚未招募2 期

Efficacy of Dashamulaadi Kaala Basti and Rasaayana Churna in the Management of Madhumeha Janya Vrikka Vikara w.s.r. Diabetic Nephropathy (An Exploratory Clinical Study)

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Known type II diabetic patients with urine
  • albumin >30 mg in 24 hours urine sample.
  • 2. Patient having Blood Pressure (BP) <= 200/120
  • 3. Age in between 40 and 70 years irrespective of gender.
  • 4. Patients eligible for Basti treatment.
  • 5. Patient up to Stage 4 of kidney disease.

排除标准

  • 1. Micro-albuminuria induced due to other
  • diseases such as pregnancy and chronic renal
  • 2. Patients with other severe complications of
  • DM such as ketoacidosis and Uraemia.
  • 3. Plasma Creatinine more than 5 mg/dl.
  • 4. Any other serious systemic illness.
  • 5. Patient contraindicated for Basti.

研究者

相似试验